How Do I Get My Medical Reps to Balance Reach and Frequency?
Set a weighted coverage scorecard instead of counting calls. Define target reach percentage, frequency on high-decile accounts, and new-target activation, weight each by strategic priority, score reps 1-to-5, and pay on the composite. Reps camping on three friendly offices score high on frequency and low on reach — the gap becomes visible and coachable.
Signals you actually need this
The clearest tell is a call log that looks healthy and a territory that isn't growing. A rep logs 240 calls in a month, hits 110% of activity quota, and the district still misses number. Pull the account-level detail and you usually find the same pattern: 60-70% of those calls landed on eight to twelve accounts, and the other 130 targets on the list got either one touch or none. That isn't laziness. It's rational behavior under a metric that rewards volume without asking where the volume went.
Watch for these specific signals before you build anything:
Reach percentage below 60% on the defined target list. If your call plan names 150 physicians and only 85 saw a rep in the quarter, you have a reach problem, not a frequency problem. Adding calls won't fix it — the calls will go to the same 85. Most field organizations consider 80-90% quarterly reach on tier-one and tier-two targets a reasonable floor, though the right number depends on decile mix and geography.

Frequency wildly uneven inside the covered set. Compute calls-per-reached-account and look at the distribution, not the average. An average of 4.2 calls per account can hide a reality where twelve accounts got 14 touches and seventy-three got one. The standard deviation tells you more than the mean here. A healthy distribution is tight around your target cadence for each tier; a broken one has a long right tail on a handful of names.
New-target activation near zero. Count the accounts that received a first-ever call this quarter. If that number is under 5% of the target list for a rep who's been in territory more than a year, they've stopped prospecting inside their own patch. This is the single most predictive leading indicator of a flat territory twelve months out.
Reps who can't tell you their bottom-decile names. Ask a rep to list the ten targets they've called least this quarter. If they can't, they aren't managing a territory, they're managing a route. Reps with balanced coverage generally know exactly who they're behind on, because they're actively deciding.

District-level variance without territory-level explanation. When two reps with comparable target lists and comparable geography produce very different growth and similar call counts, the difference is almost always in the coverage profile, not the effort level. That's the moment a scorecard stops being administrative overhead and starts being the only way to see what's happening.
Sample or educational-material delivery clustering. In pharma and device, the physical-material trail is an honest audit of where a rep actually was. If 80% of samples went to the same handful of offices, the coverage story is already written.
One adjacent signal worth naming: this pattern is not unique to medical. Field-service organizations, industrial distribution, and route-based CPG all show the identical failure mode — a comfort cluster forms, the activity metric stays green, and the account base quietly narrows. The medical version is just higher stakes, because access to a physician is scarce, expensive, and often gated by compliance rules that limit how many times you can knock on the same door anyway.
What good looks like versus what bad looks like
Bad looks like a single number. One call count, one activity quota, one leaderboard sorted descending. It creates exactly one behavior: maximize touches at minimum friction cost. The lowest-friction touch is always the office where the staff knows your name, the parking is easy, and the physician will give you ninety seconds without an appointment. A rep optimizing that metric honestly and diligently will end up with a narrow territory. The metric did that, not the rep.
Good looks like a composite across seven to ten behaviors, each weighted, each scored on a 1-to-5 scale, rolled into one number. The formula is plain: composite = Σ (weight × level). Nothing exotic. The power is entirely in what you choose to weight.
Here's a workable starting matrix for a medical field team. Weights are illustrative — set yours with commercial leadership, because the weights *are* the strategy:

| Behavior | Illustrative weight |
|---|---|
| Target reach % (tier 1+2) | 25 |
| Frequency compliance on high-decile accounts | 20 |
| New-target activation rate | 15 |
| Geographic/territory coverage breadth | 10 |
| CRM call-logging accuracy and timeliness | 10 |
| Sample & educational material compliance | 8 |
| Follow-up cadence consistency | 7 |
| Formulary/access progress | 5 |
Score each line 1-to-5 against published criteria. A level 5 on reach might mean ≥90% of tier-one and tier-two targets touched in the quarter; level 3 means 70-79%; level 1 means under 55%. Write those bands down and publish them. If a rep has to ask what a 4 means, the scorecard is decoration.
Now run the math on the two archetypes. The camper scores 5 on frequency (20 × 5 = 100), 1 on reach (25 × 1 = 25), 1 on activation (15 × 1 = 15), and middling elsewhere. The territory-builder scores 3 on frequency (60), 4 on reach (100), 5 on activation (75). Same call count. Composite gap of roughly 100 points. That gap is the coaching conversation, and it's no longer a matter of opinion.
Two more markers separate good from bad. First, good is re-weightable overnight. A product launches, a formulary decision lands, a competitor loses an indication — you change the weights, republish, and the field re-aims the next morning without a new comp plan or a road show. Bad is a metric frozen in a comp document you can't touch until January. Second, good is visible to the rep continuously. If a rep sees their levels only at the quarterly review, the scorecard is a report card. If they see it weekly, it's a steering wheel. That distinction determines whether behavior actually changes.

The failure mode to avoid on the "good" side is over-instrumenting. Twelve-plus KPIs dilute attention until nothing is prioritized. Eight is a sane ceiling. If a behavior isn't worth at least 5% of the weight, cut it and coach it verbally instead.
The trade-off nobody names: reach and frequency compete for the same hours
This is where most scorecard rollouts quietly fail. Reach and frequency are not two independent dials — they draw from one fixed pool of selling hours. A rep with 150 targets, roughly 8-10 productive field calls a day, and about 20 selling days a month has something on the order of 160-200 calls to allocate. If tier-one accounts need a touch every two weeks, and you have 40 of them, that's 80 calls gone before anyone else gets a visit. The remaining 110 targets are competing for what's left.
So the honest framing for your reps isn't "do more of both." It's "here is the allocation we've decided on, and here's why." A defensible starting split for a mixed-decile medical territory:

- Tier one (top decile, high writers/high volume): 45-55% of calls, targeting a 2-week cadence.
- Tier two (mid-decile, growth potential): 25-35% of calls, targeting a 4-6 week cadence.
- Tier three (low decile, coverage/maintenance): 10-15% of calls, quarterly touch.
- New/unactivated targets: 5-10% of calls, held as a protected reserve.
That last line is the one that matters most and gets cut first when a rep is behind. Protect it explicitly in the matrix — give activation its own weighted line so it can't be sacrificed silently.
There's a real diminishing-return curve on frequency, too. Somewhere past a certain cadence per account, additional calls stop producing incremental behavior change and start producing access damage — office staff begin screening you out, and you burn the relationship you were trying to deepen. Compliance and access policies at many health systems already cap visit frequency for exactly this reason. Rather than guess at a universal threshold, measure it in your own data: plot calls-per-account against the outcome metric you actually care about and find where your curve flattens. Then set frequency level 5 at the flattening point, not above it. A scorecard that rewards frequency past the point of return teaches reps to annoy their best accounts.
The geographic constraint compounds this. A rural territory with 90-minute drives between clusters physically cannot hit the same reach as a dense metro territory with twelve offices in one medical park. Normalize for it, or your rural reps will correctly conclude the scorecard is rigged and stop trying. Two workable approaches: set reach targets per-territory based on drive-time modeling, or score reach as improvement-versus-own-baseline rather than absolute percentage. The second is easier to implement and harder to game than it sounds, because the baseline is the rep's own prior-period number.

Real cost, ROI ranges, and what you actually pay for
The scoring methodology itself is free. It's arithmetic. What costs money is the data layer that feeds it and the visibility layer that keeps it in front of reps daily. Budget in those two buckets separately, because conflating them is how teams end up buying an enterprise platform to solve a spreadsheet problem.
The data layer. Life-sciences CRM — Veeva CRM, IQVIA's orchestrated engagement platform, Salesforce Health Cloud — is where reach, frequency, call plans, and territory coverage come from natively. These are custom enterprise quotes, per-user annual licensing, and if you're a medical field organization of any size you almost certainly already own one. The relevant question isn't whether to buy it; it's whether you're extracting coverage analytics from it or just using it as a call log. Most teams are doing the latter. Before you spend a dollar, ask your CRM admin to build a reach-and-frequency report by rep by tier. If that report can be built from data you already have, your incremental cost for the scorecard is zero plus admin hours.
The visibility layer. This is where reasonably-priced tools live. Gamification and scorecard-broadcast platforms — Spinify, Ambition, Hoopla — put the composite on a leaderboard, a TV, or a Slack channel so it stays live rather than quarterly. Published entry pricing in this category commonly starts in the low tens of dollars per user per month, with enterprise tiers quoted. Compensation-tracking tools like QuotaPath wire the composite to the paycheck, which is the sharpest teeth available; they publish a free tier and paid plans in a similar range. Route and territory-mapping tools like Map My Customers attack the geographic half of the reach problem directly, and typically price higher per seat because they're doing real routing work. Check current pricing pages before you budget — these move.

The build-it-yourself path. A spreadsheet does this correctly. List drivers, set weights with leadership, score 1-to-5, let a formula roll the composite. Free, transparent, and fully under your control. The failure rate is high for one boring reason: a sheet that requires manual scoring every month gets abandoned by month three. If you go this route, put a named owner and a calendar-recurring 90-minute block on it, or accept that it will die.
Honest ROI framing. Don't promise a percentage. The mechanism is what's defensible: if 40% of your target list is currently receiving effectively zero coverage, and you shift 15-20% of call volume from over-served accounts to under-served ones, you're exposing a meaningful block of prescribers or purchasers to your message for the first time. Whether that converts depends on your product, your access, your competitive position, and your therapeutic area. What you *can* commit to measuring: reach percentage, activation count, and the composite trend — all of which move within one quarter and all of which are leading indicators you can act on now rather than lagging revenue you can only explain later.
The cost of *not* doing it is easier to quantify. Take a fully-loaded medical rep cost — salary, benefits, car, samples, and territory expense — and divide by the share of the target list they're actually covering. A rep covering 55% of their list is, in coverage terms, delivering a little over half the territory you're paying for. That's the number to bring to the budget conversation, and it makes the visibility-layer spend look small.
One RevOps note worth flagging: the scorecard is only as honest as CRM hygiene. If reps log calls in batches on Friday from memory, or log a call for a signature drop that never involved a conversation, your reach number is fiction. Weight logging accuracy explicitly, audit a random 5% of calls monthly against sample records or signature timestamps, and be willing to zero a line item for falsified data. A scorecard built on dirty inputs produces confident wrong answers, which is worse than no scorecard.

How it plugs into your workflow
The scorecard is not a new system to run alongside your existing cadence — it should replace the artifact you already use in three recurring meetings, or it won't survive contact with a busy quarter.
Weekly (rep + self). The rep opens their own coverage view. Two questions only: who's overdue against tier cadence, and who on the target list hasn't been touched this quarter. That produces next week's route. Fifteen minutes.
Biweekly or monthly (rep + district manager). The one-on-one runs off the composite, not the call log. The manager's job is to look at the *shape* of the score, not the total. A 3.2 composite built on high reach and low frequency is a completely different coaching problem than the same 3.2 built on the inverse. First case: the rep is spreading thin and not landing depth where it pays — tighten the tier-one cadence. Second case: the rep is comfortable — assign fifteen specific uncovered names and check them next cycle. Naming the accounts is what makes this work. "Improve your reach" is not a coaching instruction; "these fifteen offices, by the 30th" is.

Quarterly (leadership). Re-examine the weights. Did the strategy shift? Did a product launch, a label expand, a formulary decision land? Adjust, republish, and communicate the change with the reasoning attached. Reps accept re-weighting when the logic is visible and resent it when it appears silently in a comp statement.
Rollout sequence that tends to hold. Run the matrix in shadow mode for one full quarter — score everyone, publish the scores, change nothing about compensation. This surfaces data problems, exposes territory normalization issues, and gives reps a quarter to react without money at risk. Then attach recognition in quarter two. Then attach a modest share of variable comp — often something in the range of 10-20% of the bonus — in quarter three. Wiring dollars to a scorecard you haven't pressure-tested is the fastest way to generate both gaming and grievance.
Expect gaming, and design against it. Every metric gets optimized, including the ones you didn't intend. Reach targets produce drive-by signature calls that satisfy the count and accomplish nothing. Counter it by requiring a logged discussion topic and, where compliance allows, spot-auditing against sample-signature timestamps and office-visit records. Activation counts produce one-and-done first calls with no follow-up, so define activation as first call *plus* a second within the cadence window, not a single touch. The general rule: score outcomes-adjacent behaviors rather than raw events wherever your data supports it.
The adjacent-workflow payoff is worth planning for. Once you have per-rep coverage data structured this way, the same feed serves territory alignment (which patches are overloaded and can't be covered by one person), hiring cases (a territory with 200 targets and 55% reach is a headcount argument with evidence), marketing coordination (target non-personal promotion at the accounts field coverage can't reach), and onboarding ramp measurement (a new rep's activation curve is a cleaner ramp signal than their revenue, which lags by two quarters). That's the RevOps case for building it properly once rather than as a manager's side spreadsheet.
Related questions
How many KPIs should the scorecard have?
Seven to ten. Below seven you're not capturing enough of the behavior mix to prevent gaming; above ten each line carries so little weight that reps ignore the tail. If a behavior can't justify at least 5% of total weight, coach it verbally instead of scoring it.
Should the composite score drive compensation immediately?
No. Run it in shadow mode for a full quarter, attach recognition in the second quarter, then wire a modest share of variable comp — commonly 10-20% of bonus — in the third. Attaching dollars to an untested matrix generates gaming and grievance before it generates coverage.
How do I keep rural reps from being penalized on reach?
Normalize for drive time. Either set per-territory reach targets from a drive-time model, or score reach as improvement against the rep's own prior-period baseline. A single absolute percentage across dense metro and rural territories reads as rigged, and reps stop engaging with the whole scorecard.
What if a rep's frequency is high because the account genuinely needs it?
Then your tier definition is wrong, not the rep. High-need accounts should sit in tier one with an explicitly higher cadence target, so the frequency is credited rather than penalized. Fix tiering annually and whenever a major account changes volume or ownership.
Does this work for a three-rep team?
Yes, and it's easier. With few reps you can tune KPI definitions to each territory's specifics and review scores in a single meeting. The composite's real value at small scale isn't ranking — it's giving each rep an objective picture of their own coverage gaps.
FAQ
How long does it take to stand up a weighted scorecard?
The matrix itself takes a few days: list the coverage behaviors, draft weights, write the 1-to-5 band definitions, and score one cycle by hand to sanity-check it. The real time goes to two things — aligning commercial leadership on the weights, which is a strategy conversation disguised as an admin task, and validating that your CRM data can actually produce the reach and frequency numbers cleanly. Budget two to four weeks end to end before the first published score.
Will reps push back on a system that penalizes their favorite accounts?
Some will, and the objection is usually framed as "you're punishing me for my strongest relationships." Reframe it accurately: the scorecard doesn't penalize depth, it stops paying for depth *alone*. Frequency still carries real weight. What changes is that a rep can no longer score well on frequency while ignoring 60% of the list. Publishing the full matrix — every weight, every scoring band — is what converts this from a trust argument into a math argument, and most resistance drops once reps can see exactly how to move their own number.
What happens when a product launches or a formulary decision changes priorities mid-quarter?
You re-weight. That's the point of a weighted composite rather than a fixed comp formula. Raise the weight on reach for the launch product's target list, republish the matrix with a short note explaining the change, and the field re-aims within days. Do this with the reasoning attached and visible — silent re-weighting reads as moving the goalposts and costs you more credibility than the pivot gains.
How do I pick which KPIs to include?
Start from the behaviors that demonstrably drive territory growth in your business: target reach on tier one and two, frequency compliance on high-decile accounts, new-target activation, geographic coverage, CRM logging accuracy, and any product-specific or access-related metrics that matter this year. Then cut until you're at eight or fewer. The test for inclusion is whether you'd genuinely change a rep's coaching plan based on that line moving — if not, it doesn't belong on the matrix.
Can this approach be adapted outside medical field sales?
The structure transfers cleanly to any territory-based field model — industrial distribution, food service, route-based CPG, field service. What has to be re-specified is the tiering logic and the cadence targets, because those depend on how buying decisions get made in that market. Medical carries an additional constraint most other verticals don't: access is gated and often formally capped, which puts a hard ceiling on frequency that the scorecard has to respect rather than push against.
What's the biggest implementation mistake to avoid?
Building it on unaudited CRM data. If reps batch-log calls from memory or record signature drops as detailed discussions, your reach percentage is fiction and the composite will confidently rank the wrong people. Weight logging accuracy as its own line, audit a random sample monthly against sample records or timestamps, and be visibly willing to zero that line for falsified entries. A scorecard on dirty inputs is worse than no scorecard, because it launders a guess into a number people trust.
Sources
- https://www.veeva.com/products/crm/
- https://www.iqvia.com/solutions/commercialization
- https://www.salesforce.com/health/
- https://spinify.com/pricing/
- https://ambition.com/
- https://www.quotapath.com/pricing/
- https://mapmycustomers.com/pricing/
- https://www.ama-assn.org/practice-management/sustainability/pharmaceutical-representative-guidelines
- https://hbr.org/2012/07/how-to-really-motivate-salespeople
- https://www.mckinsey.com/industries/life-sciences/our-insights
Related on PULSE
- [How Many Sales Reps Do I Need to Hire for My Logistics Company?](/knowledge/tl0058)
- [How Many Producers Do I Need to Hire for My Insurance Agency to Grow My Book?](/knowledge/tl0015)
- [How Many Salespeople Do I Need to Hire for My Car Dealership?](/knowledge/tl0052)
- [How Do I Figure Out How Many People to Schedule Each Day and at What Times for My Single Store?](/knowledge/tl0002)
- [How Many Attendants Should I Schedule Each Day at My Car Wash?](/knowledge/tl0067)










